These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1721321)

  • 21. Selective inhibition of CD4 graft-versus-host activity in IL-2-treated mice.
    Sykes M; Abraham VS; Harty MW; Pearson DA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1225-6. PubMed ID: 8442096
    [No Abstract]   [Full Text] [Related]  

  • 22. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolytic T cells responding to minor histocompatibility antigens.
    Mobley JL; Rigby SM; Dailey MO
    J Immunol; 1994 Dec; 153(12):5443-52. PubMed ID: 7527441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent.
    Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
    Transplant Proc; 1990 Jun; 22(3):1059-60. PubMed ID: 1971971
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
    Wecker H; Grusby MJ; Auchincloss H
    Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
    [No Abstract]   [Full Text] [Related]  

  • 28. Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
    Margenthaler JA; Kataoka M; Flye MW
    Transplantation; 2003 Jun; 75(12):2119-27. PubMed ID: 12829922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity.
    Saitoh T; Ikarashi Y; Ito S; Watanabe H; Fujiwara M; Asakura H
    J Immunol; 1990 Nov; 145(10):3268-75. PubMed ID: 2121823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice.
    Rosenberg AS
    Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanism of rejection of MHC class II-disparate murine skin grafts. I. Immunohistochemical analysis of T-cell subsets infiltrating the site of the graft.
    Kobayashi E; Fujiwara M
    Transplant Proc; 1992 Feb; 24(1):419-22. PubMed ID: 1531715
    [No Abstract]   [Full Text] [Related]  

  • 34. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell suppression in transplantation tolerance through linked recognition.
    Davies JD; Leong LY; Mellor A; Cobbold SP; Waldmann H
    J Immunol; 1996 May; 156(10):3602-7. PubMed ID: 8621893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin.
    Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
    Transplant Proc; 1994 Apr; 26(2):851-4. PubMed ID: 7513476
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of T lymphocytes cultured from cardiac biopsies following heart transplantation--appearance of cells expressing both CD4 and CD8 antigens.
    Suitters AJ; Rose ML; Dominquez MJ; Yacoub MH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):468-9. PubMed ID: 2495613
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
    Krieger NR; Fathman CG
    J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
    [No Abstract]   [Full Text] [Related]  

  • 40. Rejection of human xenoskins by non-CD4 T-cell populations in mice.
    Uchida T; Tomita Y; Zheng QW; Kishihara K; Nomoto K; Yasui H
    Transplant Proc; 1996 Apr; 28(2):662. PubMed ID: 8623332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.